Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
MINE-R regimen
Introduction
Synonyms and keywords: Mesna-Ifosfamide-Novantrone-Etoposide-Rituximab Regimen; MINE-R Regimen
Overview
Overview
MINE-R regimen refers to a regimen consisting of mesna, ifosfamide, mitoxantrone, etoposide, and rituximab used to treat relapsed or refractory Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.[1]
Regimen
Regimen
MMesna
IIfosfamide
NMitoxantrone (Novantrone)
EEtoposide
RRituximab
References
References
- ↑ 1.0 1.1 Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F; et al. (2003). “Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group”. Blood. 101 (2): 420–4. doi:10.1182/blood.V101.2.420. PMID 12509381.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]